In one succinct paragraph you've encapsulated why our IP is infinity superior to that of MSB ... and why sooner or later one of our allied Japanese companies will come knocking with a major takeover deal ... just like our ongoing trials ( funded by friendly outsiders ) , all we need is some patience ...
Ann: Further GvHD Clinical Data Published in Nature Medicine, page-13
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.0¢ |
Change
0.010(5.56%) |
Mkt cap ! $34.32M | |||
| Open | High | Low | Value | Volume |
| 18.0¢ | 19.5¢ | 18.0¢ | $9.062K | 48.88K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 104632 | 18.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.0¢ | 3 | 1 |
View Market Depth
| Last trade - 14.37pm 12/09/2024 (20 minute delay) ? |
| CYP (ASX) Chart |